Trial intelligence / Profile preview

Sodium hypochlorite vs sodium hypochlorite + chlorhexidine + calcium hydroxide in apical periodontitis

IRCT201502169014N55Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Sep 2014
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of sodium hypochlorite, chlorhexidine and calcium hydroxide in apical periodontitis (AP) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Antibacterial effect on endodontic lesion. Started Sep 2014; status: completed.

02

Drugs

sodium hypochloritechlorhexidinecalcium hydroxide
03

Conditions

apical periodontitis (AP)

Beyond the preview

Go deeper on IRCT201502169014N55.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201502169014N55.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call